Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cysteine engineered antibody drug conjugates

Cysteine engineered antibody drug conjugates

US Patent 11364303 · Granted Jun 21, 2022

Estimated economic value: $765,172,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Antibody molecules that bind to NKP30 and uses thereof2025
Multifunctional molecules that bind to T cell related cancer cells and uses ther2025
Antibodies specific for GUCY2c and uses thereof2025
Calicheamicin derivatives and antibody drug conjugates thereof2024
Calicheamicin derivatives and antibody drug conjugates thereof2024
Heteroaryl sulfone-based conjugation handles, methods for their preparation, and2023
Heteroaryl sulfone-based conjugation handles, methods for their preparation, and2023
Antibodies and antibody-drug conjugates specific for CD123 and uses thereof2023
Antibodies and antibody-drug conjugates specific for CD123 and uses thereof2023
Antibody-drug conjugates with high drug loading2023
Antibodies specific for GUCY2c and uses thereof2022